科拓生物：公司在内蒙古呼和浩特市建设的新产能已满足投产条件

Core Viewpoint - The company, Keta Bio (300858), has announced that its subsidiary, Jinhua Galaxy Factory, will maintain a high capacity utilization rate in the first half of 2025, and new production capacity in Hohhot, Inner Mongolia, has commenced trial production [1] Group 1 - The company has confirmed that the new production capacity in Hohhot has met the conditions for production and has recently started trial operations [1] - The company plans to gradually release production capacity based on customer order conditions, implementing a phased production approach [1]